This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Prothrombin Time Testing Market

Market Insights on Prothrombin Time Testing covering sales outlook, demand forecast & up-to-date key trends

Prothrombin Time Testing Market Size, Industry Share & Trends – 2032

Prothrombin Time Testing Market Outlook

The prothrombin time testing market is likely to register a CAGR of 5% during the forecast period, and is anticipated to reach a market share of US$ 10.38 Bn in 2032, from US$ 6.07 Bn in 2021, owing to the public awareness regarding the benefits and effectiveness of these devices for detecting the blood disorders.

Attributes

Details

Prothrombin Time Testing Market CAGR

5%

Prothrombin Time Testing Market Size (2021)

US$ 6.07 Bn

Prothrombin Time Testing Market Size (2032)

US$ 10.38 Bn

The rising prevalence of cardiovascular disorders in the senior population is one of the primary factors driving the demand for Prothrombin time testing. Cardiovascular disease (CVD) and blood diseases are the main causes of death in Europe, South Asia, Africa, and the United States.

Due to an increase in the frequency of blood and cardiovascular illnesses, the global sales of prothrombin time testing is expected to develop significantly over the forecast period, thus generating a profitable opportunity for major participants in the prothrombin time testing market.

The fact that over half of all Americans are at risk for heart disease, and the percentage is rising, presents a strong chance for the sales of prothrombin time testing to grow. The major key player in the market is attempting to gain prothrombin time testing market share by including more and more technical advancements into their product, allowing it to become highly advanced and capable of producing precise results with minimal variation.

Customize this Report

Let us know your requirement to get
100% FREE customization

What Factors Influence the Growth of the Prothrombin Time Testing Market

Increased use of Point-Of-Care Testing (POCT) and home care goods is predicted to boost the sales of prothrombin time testing. Geriatric populations in various nations are more prone to cardiovascular and blood problems, which gives rise to the demand for prothrombin time testing.

Furthermore, public awareness of the benefits and usefulness of these devices in diagnosing blood problems is a crucial driver driving the demand for prothrombin time testing. Prothrombin time testing devices are getting more and more common as a result of technological developments, such as faster and easier-to-use devices with superior sensor technology, promoting the sales of prothrombin time testing.

Furthermore, physicians' preference for anticoagulation agents (such as warfarin), higher testing frequency, and strong reimbursements for medical practitioners are propelling the demand for prothrombin time testing forward.

What Restrains the Prothrombin Time Testing Market

However, the approval procedure has become time-consuming and complicated as a result of stringent restrictions imposed by various regulatory authorities, and this factor is projected to stifle the sales of the prothrombin time testing.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Regional Outlook of the Prothrombin Time Testing Market

North America, South Asia, East Asia, Europe, Latin America, Oceania, and the Middle East and Africa are the seven regions that make up the global Prothrombin time testing market. The Prothrombin time testing market is expected to be dominated by the North American region, owing to its high-quality infrastructure that caters to the market's needs.

With the current change in adoption and expansion in the medical device market, the rising demand for Prothrombin Time Testing in South Asia might become a lucrative market opportunity for key players. The demand for prothrombin time testing is growing slowly in the Middle East and Africa due to poor product penetration.

Due to continuous development by major factors to improve the accuracy of test results, both established and emerging economies are moving at a good pace. The sales of prothrombin time testing are expected to rise during the forecast period.

What is the Competitive Outlook of the Prothrombin Time Testing Market

Some of the major players in the prothrombin time testing market are NIHON KOHDEN CORPORATION, SEKISUI MEDICAL, Coagulation Sciences LLC, Universal Biosensors, F. Hoffmann-La Roche, Sysmex Corporation, Medtronic, Micropoint Biosciences, ARKRAY, Diagnostica Stago S.A.S., HemoSonics, Beckman Coulter, Grifols, and Chrono-log Corporation, Abbott, Helena Laboratories, Thermo Fisher Scientific, Siemens Healthcare GmbH and others. With novel product formulations and launches, these prominent industry players are expected to boost prothrombin time testing market share growth.

  • SPOTCHEM HS HS-7710, a blood coagulation testing product, was launched by ARKRAY, Inc. in 2019. It is faster and more efficient than other variations, and it enables for analysis in surgical areas utilizing entire blood samples. Furthermore, it is fully automated, attracting larger sales of prothrombin time testing. In terms of blood analysis in surgeries, this is unique and innovative. This highlights the importance of product development and, by extension, research and development in the market.
  • CoaguChek Vantus was introduced by Hoffman-La Roche Ltd in 2018. It's a wireless coagulation testing system for home care settings that allows patients to perform self-tests. It primarily assesses the efficacy of blood thinners and transmits data to healthcare experts for examination.
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth rate

CAGR of 5% from 2022 to 2032

Base year for estimation

2021

Historical data

2015 - 2020

Forecast period

2022 - 2032

Quantitative units

Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis

Segments covered

 Application, type, technology, end use, region

Regional scope

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand

Country scope

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa

Key companies profiled

NIHON KOHDEN CORPORATION, SEKISUI MEDICAL, Coagulation Sciences LLC, Universal Biosensors, F. Hoffmann-La Roche, Sysmex Corporation, Medtronic, Micropoint Biosciences, ARKRAY, Diagnostica Stago S.A.S., HemoSonics, Beckman Coulter, Grifols, and Chrono-log Corporation, Abbott, Helena Laboratories, Thermo Fisher Scientific, Siemens Healthcare GmbH and others

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Frequently Asked Questions

The prothrombin time testing market is anticipated to register a CAGR of 5% during the forecast period.

The prothrombin time testing market share is anticipated to reach US$ 10.383 Bn by 2032.

Demand for the prothrombin time testing market is likely to rise, owing to the public awareness regarding the benefits and effectiveness of these devices for detecting the blood disorders.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

West Nile Virus Testing Market

Published : October 2019

Healthcare

Respiratory Pathogen Testing Kits Market

Published : June 2020

Healthcare

Cell-Free Fetal DNA Testing Market

Published : January 2016

Healthcare

Nucleic Acid Testing Market

Published : December 2021

Google translate

Prothrombin Time Testing Market